14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

also be used for arrang<strong>in</strong>g the next dose<br />

<strong>of</strong> hepar<strong>in</strong>. Over dosage <strong>of</strong> hepar<strong>in</strong> can<br />

be easily reversed by giv<strong>in</strong>g protam<strong>in</strong>e<br />

sup late 1 mg per 1000 units <strong>of</strong> hepar<strong>in</strong>.<br />

Hepar<strong>in</strong>:<br />

Sulph ated carbohydrate: Different size<br />

bov<strong>in</strong>e lungs, Adm<strong>in</strong>istration parenteral<br />

do not <strong>in</strong>ject IM - only IV or deep S.C.<br />

Half-life 1 - 5 hrs - monitor aPTT.<br />

Adverse effect: hemorrhage Anti-dote:<br />

protam<strong>in</strong>e sulphate.<br />

Oral anticoagulants:<br />

Examples: Coumar<strong>in</strong>s - warfar<strong>in</strong>,<br />

dicumarol, structurally related to vitam<strong>in</strong><br />

K, Inhibits production <strong>of</strong> active clott<strong>in</strong>g<br />

factors, Clearance is slow - 36 hrs,<br />

Delayed onset 8 - 12 hrs overdose -<br />

reversed by vitam<strong>in</strong> K <strong>in</strong>fusion and can<br />

cross placenta - do not use dur<strong>in</strong>g late<br />

pregnancies.<br />

Mechanism <strong>of</strong> action:<br />

Normally, vitam<strong>in</strong> K is converted to<br />

vitam<strong>in</strong> K epoxide <strong>in</strong> the liver. This<br />

epoxide is then reduced by the enzyme<br />

epoxide reductase. The reduced form <strong>of</strong><br />

vitam<strong>in</strong> K epoxide is necessary for the<br />

synthesis <strong>of</strong> many coagulation factors (II,<br />

VII, IX and X, as well as prote<strong>in</strong> C and<br />

prote<strong>in</strong> S). Warfar<strong>in</strong> <strong>in</strong>hibits the enzyme<br />

epoxide reductase the liver, thereby<br />

<strong>in</strong>hibit<strong>in</strong>g coagulation.<br />

Warfar<strong>in</strong> side effect:<br />

Severe Side effects: Severe bleed<strong>in</strong>g<br />

from the rectum or black stool Sk<strong>in</strong><br />

conditions such as hives, a rash or<br />

itch<strong>in</strong>g. Swell<strong>in</strong>g <strong>of</strong> the face, throat,<br />

mouth, legs, feet or hands, bruis<strong>in</strong>g that<br />

comes about without an <strong>in</strong>jury you<br />

140<br />

remember, Chest pa<strong>in</strong> or pressure<br />

Nausea or vomit<strong>in</strong>g, fever or flulike<br />

symptoms. Jo<strong>in</strong>t or muscle aches<br />

diarrhea, difficulty mov<strong>in</strong>g Numbness <strong>of</strong><br />

t<strong>in</strong>gl<strong>in</strong>g <strong>in</strong> any part <strong>of</strong> your body and<br />

Pa<strong>in</strong>ful erection last<strong>in</strong>g four hours or<br />

longer.<br />

Other less serious warfar<strong>in</strong> side<br />

effects:<br />

Gas, feel<strong>in</strong>g cold, fatigue, pale sk<strong>in</strong><br />

changes <strong>in</strong> the way foods taste and Hair<br />

loss.<br />

Drug <strong>in</strong>teraction with warfar<strong>in</strong>:<br />

Category Mechanism Representati<br />

ve Drugs<br />

Drugs that<br />

Increase<br />

Warfar<strong>in</strong> Activity<br />

Drugs that<br />

promote<br />

bleed<strong>in</strong>g<br />

Warfar<strong>in</strong> activity<br />

Drugs that<br />

decrease<br />

Decrease b<strong>in</strong>d<strong>in</strong>g to<br />

Album<strong>in</strong> <strong>in</strong>hibit<br />

degradation<br />

decrease synthesis <strong>of</strong><br />

clott<strong>in</strong>g Factors<br />

Inhibition <strong>of</strong> platelets<br />

Factors<br />

Inhibition <strong>of</strong> clott<strong>in</strong>g<br />

Promote clott<strong>in</strong>g<br />

factor<br />

Reduced absorption<br />

Synthesis<br />

Aspir<strong>in</strong>,<br />

Sulfonamides<br />

Cimetid<strong>in</strong>e,<br />

Disulfiram<br />

Antibiotics<br />

(oral)<br />

Aspir<strong>in</strong><br />

hepar<strong>in</strong><br />

antimetabolit<br />

es<br />

Vitam<strong>in</strong> K<br />

Colestipol<br />

Cholestyrami<br />

ne<br />

Naphthoqu<strong>in</strong>one - This group <strong>of</strong> drugs<br />

<strong>in</strong>clude dicoumarol, and phen<strong>in</strong>dione.<br />

These drugs are chemically similar to<br />

Vitam<strong>in</strong> K. They act by replac<strong>in</strong>g<br />

Vitam<strong>in</strong> K at the site <strong>of</strong> prothromb<strong>in</strong><br />

formation. They also prevent the hepatic<br />

synthesis <strong>of</strong> factor VII, IX and X. The<br />

anticoagulant effect <strong>of</strong> hepar<strong>in</strong> is<br />

immediate and maximal after<br />

<strong>in</strong>travenous <strong>in</strong>jection, but decreases<br />

rapidly over the course <strong>of</strong> few hours.<br />

The effect <strong>of</strong> oral anticoagulants on the<br />

other hand, is negligible for the first 24

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!